Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-06-25

Clinical Trial Update: Maximum Targeted Ablation of Atrial Flutter [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on maximum targeted ablation for atrial flutter; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Atrial Flutter | Phase 4 | Status: UNKNOWN